Skip to main content
Top
Literature
1.
go back to reference Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911–20.CrossRefPubMedPubMedCentral Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911–20.CrossRefPubMedPubMedCentral
2.
go back to reference Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370:921–31.CrossRefPubMed Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370:921–31.CrossRefPubMed
3.
go back to reference Tanatar A, Karadağ ŞG, Sözeri B, Sönmez HE, Çakan M, Kendir Demirkol Y, et al. ADA2 deficiency: case series of five patients with varying phenotypes. J Clin Immunol. 2020;40:253–8.CrossRefPubMed Tanatar A, Karadağ ŞG, Sözeri B, Sönmez HE, Çakan M, Kendir Demirkol Y, et al. ADA2 deficiency: case series of five patients with varying phenotypes. J Clin Immunol. 2020;40:253–8.CrossRefPubMed
4.
go back to reference Pinto B, Deo P, Sharma S, Syal A, Sharma A. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment. Clin Rheumatol. 2021;40:3883–96.CrossRefPubMed Pinto B, Deo P, Sharma S, Syal A, Sharma A. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment. Clin Rheumatol. 2021;40:3883–96.CrossRefPubMed
5.
go back to reference Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38:569–78.CrossRefPubMedPubMedCentral Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38:569–78.CrossRefPubMedPubMedCentral
6.
go back to reference Öztürk K, Coşkuner T, Baglan E, Sönmez HE, Yener GO, Çakmak F, et al. Real-life data from the largest pediatric familial mediterranean fever cohort. Front Pediatr. 2022;9:805919.CrossRefPubMedPubMedCentral Öztürk K, Coşkuner T, Baglan E, Sönmez HE, Yener GO, Çakmak F, et al. Real-life data from the largest pediatric familial mediterranean fever cohort. Front Pediatr. 2022;9:805919.CrossRefPubMedPubMedCentral
7.
go back to reference Çakan M, Aktay-Ayaz N, Keskindemirci G, Karadağ ŞG. Two cases of periodic fever syndrome with coexistent mevalonate kinase and Mediterranean fever gene mutations. Turk J Pediatr. 2017;59:467–70.CrossRefPubMed Çakan M, Aktay-Ayaz N, Keskindemirci G, Karadağ ŞG. Two cases of periodic fever syndrome with coexistent mevalonate kinase and Mediterranean fever gene mutations. Turk J Pediatr. 2017;59:467–70.CrossRefPubMed
8.
go back to reference Nihira H, Nakagawa K, Izawa K, Kawai T, Yasumi T, Nishikomori R, et al. Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency. Scand J Rheumatol. 2018;47:170–2.CrossRefPubMed Nihira H, Nakagawa K, Izawa K, Kawai T, Yasumi T, Nishikomori R, et al. Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency. Scand J Rheumatol. 2018;47:170–2.CrossRefPubMed
Metadata
Title
Deficiency of Adenosine Deaminase 2 Presenting as Periodic Fever at the Mainland of Familial Mediterranean Fever
Authors
Mustafa Çakan
Betül Sözeri
Publication date
08-07-2022
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 7/2022
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01328-z

Other articles of this Issue 7/2022

Journal of Clinical Immunology 7/2022 Go to the issue